Unique ID issued by UMIN | UMIN000011753 |
---|---|
Receipt number | R000013746 |
Scientific Title | Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract - A Randomized Controlled Trial. |
Date of disclosure of the study information | 2013/09/13 |
Last modified on | 2017/01/30 18:28:41 |
Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract - A Randomized Controlled Trial.
Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract
Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract - A Randomized Controlled Trial.
Clinical Trial for Immunostimulating effect of Physta(R)/Eurycoma Longifolia Extract
Japan |
Healthy adults
Adult |
Others
NO
To investigate whether Tongkat Ali makes the following effects on:
a) improving the Scoring of Immunological Vigor, which is proposed as one of the indices expressing the comprehensive immunity.
b) decreasing the Immunological Age
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Scoring of Immunological Vigor
Immunological Parameters
Total testosterone, Free testosterone
Questionnaires (POMS, Likert)
Blood test
Urinary test
Physical examinations
Marketing questionnaire
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
YES
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Food |
Duration: 4 weeks
Test material: Eurycoma Longifolia root extract.......200 mg/day
Once/day
Duration: 4 weeks
Test material: Rice powder.......200mg
Once/day
40 | years-old | <= |
59 | years-old | >= |
Male and Female
a) Healthy adults, who feel fatigue daily
b) Persons whose ages are between 40 and 59 years old
c) Low immunity score (SIV less than 23) on visit 1's examination
a) Persons who have previous medical history of heart failure and cardiacinfarction
b) Patients being treated for arterial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, dyslipidemia, hypertension, and other chronic disease
c) Persons who takes medicines, herbal medicines, and dietary supplements within 30 days
d) Persons who has allergy
e) Pregnant women, lactating women, or women who want to get pregnant during the trial period
f) Pollinosis patients
g) Smokers
h) Persons who enrolled in the other clinical trials within last 3 months before the agreement for the participation to the trial
i) Persons who investigator judge not suitable to participate in the trial
80
1st name | |
Middle name | |
Last name | Kazuo YAMAMOTO |
ORTHOMEDICO, Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
kazu@orthomedico.jp
1st name | |
Middle name | |
Last name | Naoko SUZUKI |
ORTHOMEDICO, Inc.
R&D department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO, Inc.
Biotropics Malaysia Berhad
Outside Japan
Malaysia
Seishin-kai Medical Association Inc, Takara clinic.
Institute for Health & Life Science.
NO
医療法人社団 盛心会 タカラクリニック (東京都)
Seishin-kai Medical Association Inc, Takara clinic (Tokyo)
2013 | Year | 09 | Month | 13 | Day |
Published
George A, Suzuki N, Abas AB, Mohri K, Utsuyama M, Hirokawa K, Takara T. Immunomodulation in Middle-Aged Humans Via the Ingestion of Physta Standardized Root Water Extract of Eurycoma longifolia Jack-A Randomized, Double-Blind, Placebo-Controlled, Parallel Study. Phytother Res. 2016; 30(4): 627-35.
Completed
2013 | Year | 08 | Month | 05 | Day |
2013 | Year | 08 | Month | 06 | Day |
2013 | Year | 12 | Month | 13 | Day |
2013 | Year | 12 | Month | 27 | Day |
2014 | Year | 02 | Month | 28 | Day |
2014 | Year | 03 | Month | 31 | Day |
2013 | Year | 09 | Month | 13 | Day |
2017 | Year | 01 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013746